Entrectinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 February 2025

  • curprev 22:5722:57, 8 February 2025 Omid Afkhami-Ardakani talk contribs 5,425 bytes +5,425 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Entrectinib |aOrAn=a |drugClass=Tyrosine Kinase Inhibitor |indicationType=treatment |indication=Adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive. And also adult and pediatric patients 12 years of age and older with solid tumors. |adverseReactions=Fatigue, Constipation, Dysgeusia (altered taste), Edema, Dizziness, Diarrhea, Nausea, Dysesthesia (abnorma..."
Retrieved from "https://www.wikidoc.org/index.php/Entrectinib"